GlassScriptPhysician profile
Sarah Anne Moore
NPI 1538620760
$2,314.28
in general payments reported to CMS, 2019-2025
25 companies · $1,819 in 2025
The $1,819 reported for 2025 was more than what 78% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $12.35 · 2024: $483 · 2025: $1,819.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,213 · Education: $89.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,212.93 |
| Education | $89.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Procept Biorobotics Corporation | $644.33 | 2025 | |
| Abbvie INC. | $200.84 | 2025 | |
| Janssen Biotech, INC. | $178.10 | 2024-2025 | Erleada, Tremfya |
| Boston Scientific Corporation | $162.03 | 2025 | Axonics, Rezum Generator |
| Medtronic, INC. | $155.78 | 2025 | Interstim |
| Axonics, INC. | $147.83 | 2024 | Axonics |
| Sumitomo Pharma America, INC. | $98.33 | 2025 | Gemtesa, Orgovyx |
| Olympus America INC. | $84.91 | 2025 | Itind System |
| Urogen Pharma, INC. | $75.38 | 2025 | |
| Teleflex LLC | $73.49 | 2024-2025 | Urolift |
| Accord Healthcare, INC. | $70.01 | 2024-2025 | |
| Laborie Medical Technologies Corp. | $65.12 | 2025 | |
| Dermavant Sciences, INC. | $46.16 | 2024 | Vtama |
| Endo USA, INC. | $45.56 | 2024 | Xiaflex |
| Pfizer INC. | $39.19 | 2024-2025 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Calyxo, INC. | $33.67 | 2025 | Cvac Aspiration System |
| Verity Pharmaceuticals INC. | $33.19 | 2025 | Trelstar |
| Merck Sharp & Dohme LLC | $32.69 | 2025 | Keytruda |
| Koelis INC. | $26.21 | 2024 | |
| Novo Nordisk INC | $23.95 | 2024 | |
| Immunitybio, INC. | $23.42 | 2024 | |
| Biotissue Holdings INC. | $16.33 | 2025 | |
| Myriad Genetic Laboratories, INC. | $14.91 | 2024 | Myrisk |
| Cook Medical LLC | $12.35 | 2020 | |
| Organon LLC | $10.50 | 2025 | Vtama |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sarah Moore listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.